by Wyn Staheli, Director of Content - innoviHealth
Apr 26th, 2022
As of October 2017, there were several revisions to pulmonary hypertension coding. Although these codes have been around for quite some time, it would be good to review the rationale behind the reasons for the changes. The following information comes from the request for the code revisions (emphasis added).
Pulmonary hypertension (PH) is clinically classified into five groups, based on categories that share similar pathological findings, hemodynamic characteristics and management. Group 1: Pulmonary Arterial Hypertension (PAH) Group 2: PH due to left heart disease Group 3: PH due to lung diseases and/or hypoxia Group 4: Chronic Thromboembolic PH (CTEPH) Group 5: PH with unclear multifactorial mechanisms |
This information can help provide valuable decision-making information on code selection.
References/Resources
About Wyn Staheli, Director of Content - innoviHealth
Wyn Staheli is the Director of Content Research for innovHealth. She has over 30 years of experience in the healthcare industry. With her degree in Management Information Systems (MIS), she has been a programmer for a large insurance carrier as well as a California hospital system. She is also the author and editor of many medical resource books and the founder of InstaCode Institute.